4.8 Article

ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism

Journal

SCIENCE ADVANCES
Volume 7, Issue 2, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aba7381

Keywords

-

Funding

  1. Independent Research Fund Denmark (DFF) [4183-00450]
  2. CellPAT, a Danish National Research Foundation Center of Excellence [DNRF135]
  3. Lundbeck Foundation (BRAINSTRUC) [R155-2015-2666]
  4. Novo Nordisk Foundation [NNF18OC0052105]
  5. Carlsberg Foundation [CF18-0067]
  6. Hungarian National Research, Development and Innovation Office OTKA [K119374, KH130376]

Ask authors/readers for more resources

ITIH4 is a poorly characterized plasma protein that is cleaved by human proteases to function as a protease inhibitor, forming inhibitory complexes with executing proteases. It inhibits specific proteases by sterically preventing larger substrates from accessing their active sites, while still allowing smaller substrates to be processed.
Inter-alpha-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is proteolytically processed in multiple pathological conditions. However, no biological function of ITIH4 has been identified. Here, we show that ITIH4 is cleaved by several human proteases within a protease-susceptible region, enabling ITIH4 to function as a protease inhibitor. This is exemplified by its inhibition of mannan-binding lectin-associated serine protease-1 (MASP-1), MASP-2, and plasma kallikrein, which are key proteases for intravascular host defense. Mechanistically, ITIH4 acts as bait that, upon cleavage, forms a noncovalent, inhibitory complex with the executing protease that depends on the ITIH4 von Willebrand factor A domain. ITIH4 inhibits the MASPs by sterically preventing larger protein substrates from accessing their active sites, which remain accessible and fully functional toward small substrates. Thus, we demonstrate that ITIH4 functions as a protease inhibitor by a previously undescribed inhibitory mechanism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available